ArticleProceedings of the National Academy of Sciences of the United States of America2025
Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapy.
Ofer Mandelboim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.